Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 3: Part D Drug Management Programs Following Adoption of the Comprehensive Addiction and Recovery Act

Published date05 January 2018
Law FirmEpstein Becker & Green
AuthorHelaine Fingold,Constance Wilkinson,Lesley Yeung
Subject MatterCMS,Medicare,Medicare Advantage,Prescription Drugs,Medicare Part D,Enrollment,Comment Period,Pharmaceutical Industry,Opioid,Proposed Rules

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT